Partner with the only dedicated forum bringing together key GI leaders in targeted and immune therapies, clinical trials and diagnostic fields.
Discuss how to optimize the administration of therapies to stimulate antitumor response and advance your GI therapy pipelines (alongside large pharma, biotech, academia, and technology providers).
Research into targeted, immune-combination and diagnostic therapies in GI cancers is entering a new era. With this, the gastrointestinal cancer market is looking to fast-track GI candidates to the high level of impact the patients need through various novel therapies, optimized existing treatments, and better understandings of resistances.
If you are a provider of assays, anatomic pathology services, preclinical screening work, or a clinical research provider, this is a unique opportunity to grow your business. Whether you need to communicate exciting progress to key decision-makers, generate leads, or are researching what next-generation investments the market wants, you can rely on our bespoke sponsorship to achieve your commercial goals. Download our conference brochure to find to more.
4 Key Reasons to Partner:
Meet and Network with Industry Pioneers
With a room full of drug developers looking to see how they can produce the safe and efficacious autoimmune therapies, fill your pipeline with new leads through 1-2-1 virtual meetings and virtual networking opportunities
Generate Commercial Collaborations
Make sure your hottest prospects are in the 'room' and part of the discussion, by having a wish-list of your choice contacted in advance of the event
Benefit from Market Intelligence
Discover what solutions and services companies will be investing into complement therapeutics to enable you to match your solutions accordingly
Raise Brand Awareness
Increase your reach and exposure to new clients, customers, and businesses through unique branding opportunities pre and post-conference